Congress Asset Management Co. Buys 34,328 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Congress Asset Management Co. boosted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 24.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 173,517 shares of the company's stock after acquiring an additional 34,328 shares during the period. Congress Asset Management Co. owned approximately 0.19% of Acadia Healthcare worth $5,261,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ACHC. GAMMA Investing LLC increased its holdings in Acadia Healthcare by 7,291.8% during the 1st quarter. GAMMA Investing LLC now owns 176,220 shares of the company's stock worth $5,812,000 after purchasing an additional 173,836 shares in the last quarter. Phocas Financial Corp. boosted its position in shares of Acadia Healthcare by 30.6% during the fourth quarter. Phocas Financial Corp. now owns 94,320 shares of the company's stock worth $3,740,000 after buying an additional 22,095 shares during the period. Public Employees Retirement System of Ohio bought a new position in shares of Acadia Healthcare during the fourth quarter worth about $1,293,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Acadia Healthcare by 22.0% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 313,709 shares of the company's stock valued at $12,439,000 after buying an additional 56,647 shares during the last quarter. Finally, Voloridge Investment Management LLC bought a new stake in Acadia Healthcare in the 4th quarter valued at approximately $15,770,000.

Acadia Healthcare Stock Performance

ACHC traded down $0.64 during trading on Thursday, hitting $22.13. The stock had a trading volume of 1,163,367 shares, compared to its average volume of 1,758,225. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The company has a 50 day moving average price of $23.98 and a 200-day moving average price of $33.43. Acadia Healthcare Company, Inc. has a one year low of $20.36 and a one year high of $82.41. The firm has a market cap of $2.04 billion, a price-to-earnings ratio of 7.26, a P/E/G ratio of 1.46 and a beta of 0.94.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $770.51 million during the quarter, compared to analysts' expectations of $769.90 million. During the same quarter in the previous year, the business posted $0.84 earnings per share. Acadia Healthcare's quarterly revenue was up .3% on a year-over-year basis. As a group, research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on ACHC shares. Mizuho lowered their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a report on Wednesday, May 14th. Wall Street Zen raised shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Guggenheim initiated coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target on the stock. KeyCorp reduced their price objective on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Finally, Royal Bank of Canada decreased their price objective on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a report on Monday, March 3rd. Five analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $47.94.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.